SB 1254
Initials AG Page 1 House Engrossed
ARIZONA HOUSE OF REPRESENTATIVES
Fifty-sixth Legislature
First Regular Session
Senate: HHS DP 7-0-0-0 | 3
rd
Read 24-5-1-0
House: HHS DPA 5-4-0-0
SB 1254: opioids; containers; labeling; requirements; repeal
Sponsor: Senator Shamp, LD 29
House Engrossed
Overview
Allows prescription opioid containers that contain a schedule II-controlled substance to have a
red cap but must have a warning label prescribed by the Arizona State Board of Pharmacy (Board)
about potential addiction.
History
Laws 2018, First Special Session, Chapter 1 outlines requirements for prescribing, administering
using and dispensing controlled substances. Specifically, it requires containers of schedule II
opioids that are dispensed directly by a pharmacist and not for immediate use to have a red cap
and a warning label prescribed by the Board about potential addiction.
The U.S. Drug Enforcement Administration (DEA) describes schedule II drugs, substances or
chemicals as drugs with a high potential for abuse, with use potentially leading to severe
psychological or physical dependence. Some examples of schedule II drugs are: cocaine,
methamphetamine, Adderall and oxycodone (DEA).
Provisions
1. Allows containers of a schedule II-controlled substance that is an opioid and directly
dispensed by a pharmacist and not for immediate administration to the ultimate user to have
a red cap but must have a warning label prescribed by the Board about potential addiction.
2. Removes the ability of the Board or its Executive Director, if delegated by the Board, to waive
the red cap requirement if implementation is not feasible because of the specific dosage form
or packaging type. (Sec. 1)
3. Makes technical changes. (Sec. 1)
☐ Prop 105 (45 votes) ☐ Prop 108 (40 votes) ☐ Emergency (40 votes) ☐ Fiscal Note